A final rule to authorize release of additional H-2B seasonal visas primarily used by the hospitality, landscaping, and ...

A bipartisan group of forty United States senators is requesting that the U.S. Department of Labor (DOL) and U.S. Department of Homeland ...

Hospitals performed more than 200,000 unnecessary back surgeries on Medicare beneficiaries in the U.S. over three years, ...

Belize will be added to the list of countries eligible to participate in seasonal work visa programs, the Department of ...

A trucking company tried justifying its need for H-2B truck drivers by claiming the pandemic led to extremely high turnover ...

H.C. Wainwright analyst Yi Chen raised the firm’s price target on Tourmaline Bio (TRML) to $49 from $48 and keeps a Buy rating on the ...

Four losses to EWAC rival Cle Elum and a nonleague schedule full of other 2B/1B playoff teams caused significant frustration ...

Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The ...

Here are the top performers from the fifth week of AFL action: More on the Arizona Fall League: • Complete coverage | ...

The General secured five top-14 finishes at the Wrentham Developmental Center, including a runner-up performance by sophomore ...

Behind side-by-side finishes from Will Cerrutti and Nate Assa, along with an unexpected third by Jacob Szalewicz, the ...

周二，H.C. Wainwright调整了Tourmaline Bio (NASDAQ:TRML)的目标价，将其从之前的$48.00上调至$49.00，同时重申了对该股的买入评级。该公司的决定是在Tourmaline Bio上周公布2024年第三季度财务业绩后做出的。 公司报告净亏损为$20.2 million，即每股亏损($0.78)，略高于H.C. Wainwright预估的$19.3 mil ...